ABBOTINDIA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.0
| Stock Code | ABBOTINDIA | Market Cap | 54,049 Cr. | Current Price | 25,435 ₹ | High / Low | 37,000 ₹ |
| Stock P/E | 35.5 | Book Value | 1,888 ₹ | Dividend Yield | 1.87 % | ROCE | 46.2 % |
| ROE | 35.7 % | Face Value | 10.0 ₹ | DMA 50 | 26,246 ₹ | DMA 200 | 28,166 ₹ |
| Chg in FII Hold | 0.08 % | Chg in DII Hold | -0.07 % | PAT Qtr | 376 Cr. | PAT Prev Qtr | 415 Cr. |
| RSI | 42.3 | MACD | -281 | Volume | 5,620 | Avg Vol 1Wk | 18,845 |
| Low price | 25,150 ₹ | High price | 37,000 ₹ | PEG Ratio | 1.69 | Debt to equity | 0.05 |
| 52w Index | 2.41 % | Qtr Profit Var | 4.21 % | EPS | 717 ₹ | Industry PE | 30.1 |
📈 Chart Patterns & Trend: ABBOTINDIA is trading below both 50 DMA (₹26,246) and 200 DMA (₹28,166), reflecting weak momentum. RSI at 42.3 indicates bearish bias, while MACD at -281 confirms negative divergence. Bollinger Bands suggest consolidation with price near lower support levels. Price action remains closer to lows (₹25,150) than highs (₹37,000), signaling caution.
🔑 Momentum Signals: RSI below 45 signals weak buying strength. MACD negative confirms bearish bias. Volume (5,620) is far below average (18,845), showing lack of participation. Trendlines highlight support near ₹25,200–₹25,400 and resistance near ₹26,200–₹26,500.
🎯 Entry Zone: ₹25,200 – ₹25,400 (support levels)
💰 Exit Zone: ₹26,200 – ₹26,500 (resistance levels)
📊 Status: Consolidating with bearish bias; reversal unlikely unless price sustains above 50 DMA with stronger volumes.
Positive
- Strong ROCE (46.2%) and ROE (35.7%) highlight efficiency
- EPS at ₹717 reflects robust profitability
- Dividend yield at 1.87% provides income support
- Low debt-to-equity ratio (0.05) ensures financial stability
- FII holdings increased slightly (+0.08%)
Limitation
- Stock trading below both 50 DMA and 200 DMA
- Weak RSI and negative MACD indicate bearish momentum
- Quarterly PAT declined (₹376 Cr vs ₹415 Cr)
- Volume significantly below average, limiting breakout potential
Company Negative News
- DII holdings decreased (-0.07%)
- Quarterly profit contraction raises concerns
Company Positive News
- Strong efficiency metrics (ROE/ROCE)
- Dividend yield supports investor sentiment
Industry
- Industry PE at 30.1 highlights sector stability
- ABBOTINDIA trading at a slight premium (P/E 35.5)
Conclusion
⚠️ ABBOTINDIA is consolidating with weak technical momentum. Despite strong fundamentals (ROE, ROCE, EPS, dividend yield), the stock faces bearish signals due to declining profits, low volumes, and price trading below DMA levels. Best suited for cautious entries near ₹25,200–₹25,400 with profit-taking around ₹26,200–₹26,500. Sustained recovery requires earnings growth and price crossing above 50 DMA.
Would you like me to add a peer benchmarking overlay (ABBOTINDIA vs Pfizer, GSK Pharma, and Sanofi India) so you can see relative valuation and momentum gaps within the pharma sector?